Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Holtmann

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Zeitschrift Fur Gastroenterologie|October 1, 1995
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group]W Domschke, A Dettmer, T Fenner, et al.
Neurogastroenterology and Motility|June 15, 2007
A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndromeY A Saito, G R Locke, J M Zimmerman, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2003
Clinical trial guidelines for pharmacological treatment of irritable bowel syndromeE Corazziari, P Bytzer, M Delvaux, et al.
Journal of Neuroimmunology|November 23, 2006
Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remissionA Lucas, P M Cobelens, A Kavelaars, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2021
Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trialN J Talley, M M Walker, M Jones, et al.
Digestive Diseases and Sciences|May 29, 2017
The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical SettingN A Koloski, M Jones, J Hammer, et al.
Digestive Diseases and Sciences|July 10, 2017
Erratum to: The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical SettingN A Koloski, M Jones, J Hammer, et al.
Brain, Behavior, and Immunity|December 21, 2005
Visceral pain and public speaking stress: neuroendocrine and immune cell responses in healthy subjectsA Lucas, G Holtmann, G Gerken, et al.
Arthritis Research & Therapy|July 6, 2022
Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activityP R Sternes, L Brett, J Phipps, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppressionP Malfertheiner, R Fass, E M M Quigley, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Zeitschrift Fur Gastroenterologie|October 1, 1995
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group]W Domschke, A Dettmer, T Fenner, et al.
Neurogastroenterology and Motility|June 15, 2007
A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndromeY A Saito, G R Locke, J M Zimmerman, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2003
Clinical trial guidelines for pharmacological treatment of irritable bowel syndromeE Corazziari, P Bytzer, M Delvaux, et al.
Journal of Neuroimmunology|November 23, 2006
Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remissionA Lucas, P M Cobelens, A Kavelaars, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2021
Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trialN J Talley, M M Walker, M Jones, et al.
Digestive Diseases and Sciences|May 29, 2017
The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical SettingN A Koloski, M Jones, J Hammer, et al.
Digestive Diseases and Sciences|July 10, 2017
Erratum to: The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical SettingN A Koloski, M Jones, J Hammer, et al.
Brain, Behavior, and Immunity|December 21, 2005
Visceral pain and public speaking stress: neuroendocrine and immune cell responses in healthy subjectsA Lucas, G Holtmann, G Gerken, et al.
Arthritis Research & Therapy|July 6, 2022
Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activityP R Sternes, L Brett, J Phipps, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppressionP Malfertheiner, R Fass, E M M Quigley, et al.
Pageof 15